Insights
Conducting a Market Research Study to Understand the P&R Landscape for a New CAR-T Product in KSA
Project Scope
To understand the unmet need with current treatment landscape, value perception and pricing potential of a potential CAR-T therapy indicated for (2L and/or 3L+) DLBCL and 3L Follicular Lymphoma patients
KSA
Challenge
Our client wanted to understand the unmet need with current treatment landscape, value perception and pricing potential of a new CAR-T therapy indicated for (2L and/or 3L+) DLBCL and 3L Follicular Lymphoma patients in KSA
Solution
Conducted a market landscape assessment and extensive primary research to get detailed insights on:
- Satisfaction level with current treatment options and clinical benefits expected from new treatment options
- Clinical and economic value perception of a potential CAR-T product
- Expected price potential and coverage restrictions applicable to therapy after reimbursement
Results
- Enabled client to understand current treatment landscape and associated challenges with them
- Identified decision making drivers within new CAR-T therapies and understood reimbursement potential for the new product in development
Note: P&R: Pricing and Reimbursement, CAR-T: Chimeric antigen receptor therapy, KSA: Kingdom of Saudi Arabia, DLBCL: Diffuse large B cell Lymphoma
Related case studies
